Advances in systemic targeted therapy and immunotherapy have dramatically improved outcome at least in some types of solid cancer. However, metastasis to the central nervous system remains a major diagnostic and therapeutic challenge, notably in long-term survivors with cancers.
Here we invite you to our 2nd Zurich Brain Metastasis Symposium that will provide state-of-the-art presentations on current and future diagnostic and therapeutic approaches for patients with brain and leptomeningeal metastasis.
We hope to welcome you to another successful symposium of the Comprehensive Cancer Center Zürich.
Prof. Dr. med. Rolf Stahel, Chair CCCZ - Prof. Dr. med. Michael Weller, Directorate CCCZ